ChiCTR-TRC-11001578 版本V1.0 版本创建时间2015/07/21 11:41:37 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR-TRC-11001578 

最近更新日期:

Date of Last Refreshed on:

2015-05-03 17:08:51 

注册时间:

Date of Registration:

2011-09-18 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

手部肌腱断裂使用人造血管(e-PTFE)再造腱鞘防止粘连

Public title:

Reconstruction of tendon sheath by blood vessel prosthesis (e-PTFE) for preventing adhesion in patients with hand tendon rupture

注册题目简写:

English Acronym:

研究课题的正式科学名称:

手部肌腱断裂使用人造血管(e-PTFE)再造腱鞘防止粘连

Scientific title:

Reconstruction of tendon sheath by blood vessel prosthesis (e-PTFE) for preventing adhesion in patients with hand tendon rupture

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

谢伟 

研究负责人:

谢伟 

Applicant:

Wei Xie 

Study leader:

Wei Xie 

申请注册联系人电话:

Applicant telephone:

+86 13897660866

研究负责人电话:

Study leader's
telephone:

+86 13897660866

申请注册联系人传真 :

Applicant Fax:

+86 0971 5299679

研究负责人传真:

Study leader's fax:

+86 0971 5299679

申请注册联系人电子邮件:

Applicant E-mail:

oba112074@163.com

研究负责人电子邮件:

Study leader's E-mail:

oba112074@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

青海省西宁市第三人民医院

研究负责人通讯地址:

青海省西宁市第三人民医院

Applicant address:

The Third People’s Hospital of Xining, Qinghai Province

Study leader's address:

The Third People’s Hospital of Xining, Qinghai Province

申请注册联系人邮政编码:

Applicant postcode:

810005

研究负责人邮政编码:

Study leader's postcode:

810005

申请人所在单位:

青海省西宁市第三人民医院

Applicant's institution:

The Third People’s Hospital of Xining, Qinghai Province

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

西宁市第三人民医院

Primary sponsor:

The Third People’s Hospital of Xining

研究实施负责(组长)单位地址:

西宁市柴达木路52号

Primary sponsor's address:

The Third People’s Hospital of Xining

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

青海

市(区县):

Country:

China

Province:

Qinghai

City:

单位(医院):

青海省西宁市卫生局

具体地址:

西宁市城西区南川西路52号

Institution
hospital:

Xining Health Bureau. No.52, Nanchuan Xilu Road, West District, Xining

Address:

52 Nanchuan Xilu Road, West District, Xining

经费或物资来源:

青海省西宁市卫生局

Source(s) of funding:

Xining Health Bureau

研究疾病:

肌腱断裂  

Target disease:

tendon rupture

研究疾病代码:

S66.906

Target disease code:

S66.906

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

III期临床试验 

Study phase:

3

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

人造血管在防止肌腱断裂导致粘连中的作用  

Objectives of Study:

To study the effect of blood vessel prosthesis for preventing adhesion caused by tendon rupture

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

手部肌腱断裂, 且肌腱基本发育成熟的患者

Inclusion criteria

Patients with hand tendon rupture and the tendon had developed to mature.

排除标准:

机体无其他严重器质性及系统疾患

Exclusion criteria:

Without serious organic and system disease

研究实施时间:

Study execute time:

From 2011-10-01 00:00:00 To 2011-03-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2011-11-01 00:00:00 To 2011-06-30 00:00:00

干预措施:

Interventions:

组别:

A

样本量:

30

Group:

A

Sample size:

干预措施:

人造血管

干预措施代码:

Intervention:

blood vessel prosthesis

Intervention code:

组别:

B

样本量:

30

Group:

B

Sample size:

干预措施:

干预措施代码:

Intervention:

Nil

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

青海 

市(区县):

 

Country:

China

Province:

Qinghai

City:

单位(医院):

西宁市第三人民医院 

单位级别:

二级甲等 

Institution
hospital:

The Third People’s Hospital of Xining

Level of the institution:

Secondary A hospital

测量指标:

Outcomes:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 16 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表

Randomization Procedure (please state who generates the random number sequence and by what method):

randomization table

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

青海省西宁市第三人民医院骨外科

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Orthopedic Surgery, the Third People’s Hospital of Xining, Qinghai Province

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

青海省西宁市第三人民医院骨外科

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Orthopedic Surgery, the Third People’s Hospital of Xining, Qinghai Province

数据与安全监察委员会:

Data and Safety Monitoring Committee:

注册人:

Name of Registration:

 2011-10-02 00:00:00